• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
ZHOU Yu,REN Manru,GONG Xinjiang.Introduction of the guideline on clinical development of fixed combination medicinal products issued by EMA[J].Journal Of Pharmaceutical Research,2018,37(9):548-551[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 4451times   Download 3358次 QR Code for this article
Scan with your phone!
EMA关于固定复方药物临床开发指导原则介绍
周誉,任曼茹,宫新江
Font:Larger+|Default|Smaller-
(国家食品药品监督管理总局药品审评中心,北京 100022)
摘要:
欧洲药品管理局(EMA)于2017年3月发布了关于固定复方药物临床开发的指导原则,该指导原则讨论了固定复方药物临床开发过程中的考虑要点和基本技术要求。我国目前尚无类似文件,通过对该指导原则的介绍,希望对我国固定复方药物的研发和审评工作提供参考。
关键词:  欧洲药品管理局  固定复方药物  临床开发  指导原则
DOI:10.13506/j.cnki.jpr.2018.09.015
基金项目:
Introduction of the guideline on clinical development of fixed combination medicinal products issued by EMA
ZHOU Yu,REN Manru,GONG Xinjiang
(Center for Drug Evaluation, China Food and Drug Administration, Beijing 100022, China)
Abstract:
The European Medicines Agency (EMA) has recently issued an industry guidance on clinical development of fixed combination medicinal products in March 2017. This guideline addresses the considerations and clinical development requirements of fixed combination medicinal products.As there is no guidance regarding this kind of products in China currently,we hope to provide some reference for the research, development and review of fixed combination medicinal products in China by introducing this guidance.
Key words:  EMA  Fixed combination medicinal products  Clinical development  Guidance
Today's Visits:465    Total Visits:2383161
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.